Home › B-Cell Lymphoma › Tennessee › Nashville

Pag-aaral pangklinika para sa B-Cell Lymphoma sa Nashville, TN

Isang pag-aaral para sa B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Nashville. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

Nagre-recruitPhase 1/2

Sarah Cannon Research Institute, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07439653

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Nagre-recruitPhase 3

Tennessee Oncology Nashville St Thomas Midtown Clinic, Nashville
Tennessee Oncology, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Nagre-recruitPhase 2

Research Site, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06526793

Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL

Nagre-recruitPhase 3

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07516093

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2

Research Site, Franklin · 17 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07123454

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

Nagre-recruitPhase 1/2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07520006

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Vanderbilt University Medical Center, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Nagre-recruitPhase 3

Sarah Cannon Research Institute SCRI, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05254743

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

SCRI Oncology Partners, Nashville

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Pag-aaral para sa B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Nashville

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.